These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 10530780

  • 1. Peroxiredoxin I expression in human thyroid tumors.
    Yanagawa T, Ishikawa T, Ishii T, Tabuchi K, Iwasa S, Bannai S, Omura K, Suzuki H, Yoshida H.
    Cancer Lett; 1999 Oct 18; 145(1-2):127-32. PubMed ID: 10530780
    [Abstract] [Full Text] [Related]

  • 2. Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat.
    Mitsumoto A, Nakagawa Y, Takeuchi A, Okawa K, Iwamatsu A, Takanezawa Y.
    Free Radic Res; 2001 Sep 18; 35(3):301-10. PubMed ID: 11697128
    [Abstract] [Full Text] [Related]

  • 3. Interference of thyroperoxidase on immuno-cytochemical determination of steroid receptors in thyroid tissue.
    Giani C, Campani D, De Negri F, Martini L, Fabbri R, Bonacci R, Ciancia EM, Gigliotti A, Fierabracci P, Pinchera A.
    J Endocrinol Invest; 1993 Jan 18; 16(1):37-43. PubMed ID: 8445155
    [Abstract] [Full Text] [Related]

  • 4. Peroxiredoxin 5 expression in the human thyroid gland.
    Gérard AC, Many MC, Daumerie Ch, Knoops B, Colin IM.
    Thyroid; 2005 Mar 18; 15(3):205-9. PubMed ID: 15785239
    [Abstract] [Full Text] [Related]

  • 5. [Bcl-2 proto-oncogene expression in neoplastic and non neoplastic thyroid tissue].
    Branet F, Caron P, Camallières M, Selves J, Brousset P.
    Bull Cancer; 1996 Mar 18; 83(3):213-7. PubMed ID: 8695923
    [Abstract] [Full Text] [Related]

  • 6. Expression profiles of peroxiredoxin proteins of the rodent malaria parasite Plasmodium yoelii.
    Kawazu S, Nozaki T, Tsuboi T, Nakano Y, Komaki-Yasuda K, Ikenoue N, Torii M, Kano S.
    Int J Parasitol; 2003 Nov 18; 33(13):1455-61. PubMed ID: 14572508
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma.
    Kinnula VL, Lehtonen S, Sormunen R, Kaarteenaho-Wiik R, Kang SW, Rhee SG, Soini Y.
    J Pathol; 2002 Mar 18; 196(3):316-23. PubMed ID: 11857495
    [Abstract] [Full Text] [Related]

  • 8. Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome.
    Kim SH, Fountoulakis M, Cairns N, Lubec G.
    J Neural Transm Suppl; 2001 Mar 18; (61):223-35. PubMed ID: 11771746
    [Abstract] [Full Text] [Related]

  • 9. Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung.
    Park JH, Kim YS, Lee HL, Shim JY, Lee KS, Oh YJ, Shin SS, Choi YH, Park KJ, Park RW, Hwang SC.
    Respirology; 2006 May 18; 11(3):269-75. PubMed ID: 16635084
    [Abstract] [Full Text] [Related]

  • 10. Autoantibody against peroxiredoxin I, an antioxidant enzyme, in patients with systemic sclerosis: possible association with oxidative stress.
    Iwata Y, Ogawa F, Komura K, Muroi E, Hara T, Shimizu K, Hasegawa M, Fujimoto M, Tomita Y, Sato S.
    Rheumatology (Oxford); 2007 May 18; 46(5):790-5. PubMed ID: 17309887
    [Abstract] [Full Text] [Related]

  • 11. Divergent light-, ascorbate-, and oxidative stress-dependent regulation of expression of the peroxiredoxin gene family in Arabidopsis.
    Horling F, Lamkemeyer P, König J, Finkemeier I, Kandlbinder A, Baier M, Dietz KJ.
    Plant Physiol; 2003 Jan 18; 131(1):317-25. PubMed ID: 12529539
    [Abstract] [Full Text] [Related]

  • 12. Analysis of peroxiredoxin decreasing oxidative stress in hypertensive aortic smooth muscle.
    Lee CK, Kim HJ, Lee YR, So HH, Park HJ, Won KJ, Park T, Lee KY, Lee HM, Kim B.
    Biochim Biophys Acta; 2007 Jul 18; 1774(7):848-55. PubMed ID: 17556052
    [Abstract] [Full Text] [Related]

  • 13. Rapid degradation of PrxI and PrxII induced by silica in Rat2 cells.
    Seo MS, Kim JK, Lim Y, Kang SW, Cho YJ, Lee WK, Kim HJ, Cho KK, Lee KH, Rhee SG.
    Biochem Biophys Res Commun; 1999 Nov 19; 265(2):541-4. PubMed ID: 10558905
    [Abstract] [Full Text] [Related]

  • 14. Peroxiredoxin I expression in oral cancer: a potential new tumor marker.
    Yanagawa T, Iwasa S, Ishii T, Tabuchi K, Yusa H, Onizawa K, Omura K, Harada H, Suzuki H, Yoshida H.
    Cancer Lett; 2000 Aug 01; 156(1):27-35. PubMed ID: 10840156
    [Abstract] [Full Text] [Related]

  • 15. Peroxiredoxins in breast carcinoma.
    Karihtala P, Mäntyniemi A, Kang SW, Kinnula VL, Soini Y.
    Clin Cancer Res; 2003 Aug 15; 9(9):3418-24. PubMed ID: 12960131
    [Abstract] [Full Text] [Related]

  • 16. Expression of peroxiredoxin II in vascular tumors of the skin: a novel vascular marker of endothelial cells.
    Lee SC, Na YP, Lee JB.
    J Am Acad Dermatol; 2003 Sep 15; 49(3):487-91. PubMed ID: 12963914
    [Abstract] [Full Text] [Related]

  • 17. Phylogenetic analysis of cnidarian peroxiredoxins and stress-responsive expression in the estuarine sea anemone Nematostella vectensis.
    Helm RR, Martín-Díaz ML, Tarrant AM.
    Comp Biochem Physiol A Mol Integr Physiol; 2018 Jul 15; 221():32-43. PubMed ID: 29567405
    [Abstract] [Full Text] [Related]

  • 18. Oxidative/nitrosative stress and peroxiredoxin 2 are associated with grade and prognosis of human renal carcinoma.
    Soini Y, Kallio JP, Hirvikoski P, Helin H, Kellokumpu-Lehtinen P, Kang SW, Tammela TL, Peltoniemi M, Martikainen PM, Kinnula VL.
    APMIS; 2006 May 15; 114(5):329-37. PubMed ID: 16725008
    [Abstract] [Full Text] [Related]

  • 19. Peroxiredoxin I and II inhibit H2O2-induced cell death in MCF-7 cell lines.
    Bae JY, Ahn SJ, Han W, Noh DY.
    J Cell Biochem; 2007 Jul 01; 101(4):1038-45. PubMed ID: 17163455
    [Abstract] [Full Text] [Related]

  • 20. Increased expression of peroxiredoxin II confers resistance to cisplatin.
    Chung YM, Yoo YD, Park JK, Kim YT, Kim HJ.
    Anticancer Res; 2001 Jul 01; 21(2A):1129-33. PubMed ID: 11396151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.